AI assistant
Sending…
HAEMONETICS CORP — Director's Dealing 2016
May 18, 2016
31565_dirs_2016-05-18_10c6d11a-8a02-4f7a-be35-94cc655c618e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2016-05-16
Reporting Person: Simon, Christopher (Director, President & CEO)
More from HAEMONETICS CORP
Annual Report
2026
Jun 9
Proxy Solicitation & Information Statement
2026
Jun 9
Proxy Solicitation & Information Statement
2026
Jun 9
Regulatory Filings
2026
Jun 5
Regulatory Filings
2026
May 28
Annual Report
2026
May 20
Major Shareholding Notification
2026
May 13
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 1
Major Shareholding Notification
2026
Apr 30